https://www.selleckchem.com/pr....oducts/3-methyladeni
We showed that recently discovered LINC01093 is dramatically down-regulated in all malignant liver cancers; while in benign tumors LINC01093 expression is just twice decreased in comparison to adjacent samples. Our study revealed that among all measured biomarkers only down-regulated HELIS and LINC01093, up-regulated CYTOR and dysregulated HULC are perspective for differential diagnostics of liver cancers; whereasothers demonstrated discordant results and cannot be considered as potential universal biomarkers for this purpose. O
Curtir
Comentario
Compartilhar
